Evidence supporting the use of: N-acetyl-cysteine (NAC)
For the health condition: Inflammatory Bowel Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-acetyl-cysteine (NAC) is used as an adjunctive therapy in Inflammatory Bowel Disorders (IBD), such as Crohn’s disease and ulcerative colitis, primarily based on preclinical and limited clinical evidence. The rationale centers on NAC’s antioxidant and anti-inflammatory properties. It is a precursor to glutathione, a key intracellular antioxidant, and has been shown in animal models to reduce oxidative stress and modulate inflammatory pathways implicated in IBD pathogenesis.

Several animal studies have demonstrated that NAC supplementation can reduce colonic inflammation, oxidative damage, and tissue injury in chemically-induced models of colitis. For example, NAC has been shown to decrease levels of pro-inflammatory cytokines (such as TNF-α and IL-1β), inhibit NF-κB activation, and improve histopathological scores in colitis models. These findings suggest a mechanistic basis for its use in IBD.

Human data remain limited. A few small clinical trials and case series have explored NAC as an adjunct to standard therapies (like mesalamine or corticosteroids), with some studies reporting improvements in clinical symptoms and inflammatory markers, while others have shown no significant benefit. The evidence is not yet robust enough to warrant routine clinical use, but ongoing research continues to evaluate its potential.

In summary, NAC’s use in IBD is supported by promising preclinical evidence and initial human studies, but larger, well-controlled clinical trials are needed to establish its efficacy and safety. Therefore, the scientific support is modest (rated 2/5), and its use should be considered experimental or adjunctive at this time.

More about n-acetyl-cysteine (NAC)
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

2'-Fucosyllactose
akkermansia muciniphila
algal oil
aloe vera
alpha-glycosyl isoquercitrin
alpha-linolenic acid (ALA)
anthocyanins
bacillus clausii
bacillus subtilis
barberry
barley
beta caryophyllene
bifidobacterium bifidum
bifidobacterium breve
bifidobacterium infantis
bifidobacterium lactis
bifidobacterium longum
butyrate triglyceride
cat's claw
chamomile
citrus pectin
Coptis chinensis
turmeric
curcumin
dandelion
DHA (docosahexaeonic acid)
EPA (eicosapentaenoic acid)
fish oil
flaxseed
fructooligosaccharides (FOS)
inulin
isomalto-oligosaccharide
l-glutamine
lactobacillus brevis
lactobacillus casei
lactobacillus crispatus
lactobacillus fermentum
lactobacillus gasseri
lactobacillus lactis
lactobacillus paracasei
lactiplantibacillus plantarum
lactobacillus reuteri
lactobacillus rhamnosus
lactobacillus salivarius
lactococcus lactis
licorice root
luteolin
marshmallow
n-acetyl-glucosamine
n-acetyl-cysteine (NAC)
nicotinamide riboside
omega-3 fatty acids
pectin
peppermint oil
butyric acid
psyllium
reishi mushroom
saccharomyces boulardii
shiitake mushroom
slippery elm bark
specialized pro-resolving mediators (SPMs)
spirulina
streptococcus thermophilus
tributyrin
Urolithin A
vitamin C
vitamin D
vitamin D3
xylanase
xylooligosaccharides
zinc
bentonite
punarnava
rubia cordifolia
swertia
myrrh
algae
7,14-Hydroxy-Docosapentaenoic Acid
Apigenin
Andrographolide
Avocado
anthocyanidins
Acemannan
Arabinoxylan
Apocynin
Arctiin
Astragalin
Bifidobacterium
Bifidobacterium adolescentis
Brassica
Boswellic Acid
Butternut
Basidiomycota
Boswellia
Bacillus licheniformis
Bioflavonoids
Bifidobacterium animalis
Bacteria
Bifidobacteria
Bacillus
Cichoric acid
Cruciferous
Casticin
Celandine
Chirata
Cannabidiol
Enterococcus
Eicosapentaenoic Acid
Ellagitannin
Fucoidan
Fiber
Frangula
Flavans
Glycomacropeptides
Glycosphingolipids
Glutathione
Galactooligosaccharides
Glycyrrhetinic Acid
Glucosinolates